Stephen Hahn, FDA commissioner (AP Images)
PDUFA VII: FDA, industry preview their reauthorization wish lists
At its first public meeting in the runup to the reauthorization of the Prescription Drug User Fee Act, the FDA, industry and other stakeholders on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.